Thursday, 17 November 2016

No early win for Sanofi, Regeneron cholesterol drug in study

(Reuters) - Sanofi and Regeneron Pharmaceuticals said on Thursday they would continue a large clinical outcomes study with their injectable cholesterol-lowering drug Praluent.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)